Researchers have found that targeting an enzyme called PGM3 can help stop the growth of glioblastoma, the most dangerous type ...

Recent research sheds light on how changes in the chemical structure of a protein called Interleukin-6 affect lung cancer’s ...

The raise will go toward trialing the company’s lead drug for phosphomannomutase-2 congenital disorder of glycosylation, a ...